Gold in the ivory tower: equity rewards of outlicensing.
other · Level V
Where this comes from
- Record sourced from PubMed, PMID 16680129.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
An analysis of life-science initial public offerings from three time periods reveals that the equity share received by universities and their academic researchers has changed over time.
Medical subject headings
- Biomedical Research
- Biotechnology
- Investments
- Universities